Jupiter Life Line Hospitals Limited has informed the Exchange about Investor Presentation
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jupiter Life Line Hospitals reported FY26 total income of Rs 1,499.8 Cr, up 15.2% YoY, with EBITDA of Rs 343.3 Cr (up 14.4%). However, PAT was flat at Rs 194.2 Cr (only 0.2% growth) as PAT margin contracted to 12.9% from 14.9% in FY25. The company operationalized Dombivli hospital ahead of schedule in February 2026, which caused Rs 9.4 Cr operational loss in ramp-up phase and higher depreciation. Management also acquired land at Mumbai's BKC for a proposed 400-bed quaternary care hospital at Rs 354 Cr. The company outlined expansion plans targeting 2,900 total beds across Dombivli (500 beds), Pune II (500 beds), Mira-Bhayandar (300 beds), and BKC (400 beds).
The flat PAT despite strong revenue growth signals margin pressure from new hospital ramp-up costs, higher depreciation, and increased finance costs from capex funding. Near-term profitability may remain constrained as new hospitals ramp up, though the expansion pipeline supports long-term growth. Shareholders should watch for margin recovery as Dombivli and upcoming facilities reach optimal occupancy.